Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in Recurrent Wilms Tumor
NCT00187031Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of topotecan in Wilms' tumor, sponsored by St. Jude Children's Research Hospital. Primary endpoint: Response Rate (Complete and Partial Response) at 5 years. Started Nov 2002; status: completed.
02
Drugs
topotecan
03
Conditions
Wilms' tumor
Beyond the preview
Go deeper on NCT00187031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187031.